Stocktoria
MEDIFAST INC MED
MEDIFAST INC (MED) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.17% (safety: safe). FY2025 revenue was $385.8M at a -4.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.64 |
| Retained earnings / assets | 0.638 |
| EBIT / assets | -0.057 |
| Equity / liabilities | 4.055 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MED | MEDIFAST INC | 3/9 | 10.15 | — | -36% |
| JVA | COFFEE HOLDING CO INC | 2/9 | 6.89 | 13.6 | +22.6% |
| TWG | Top Wealth Group Holding Ltd | 6/9 | — | 1.1 | — |
| UTZ | Utz Brands, Inc. | 4/9 | 0.78 | 1302.2 | +2.1% |
| MKC | MCCORMICK & CO INC | 6/9 | 1.84 | 17.4 | +1.7% |
| VFS | VinFast Auto Ltd. | 4/9 | -13.01 | — | +57.9% |
| TM | TOYOTA MOTOR CORP/ | 7/9 | 2.55 | — | -1% |
About MEDIFAST INC
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.
FAQ
Is MED financially healthy?
MEDIFAST INC's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does MED pay a dividend, and is it safe?
Yes. MEDIFAST INC pays a dividend yielding about 0.17% with a -1.0% payout ratio, rated “safe” for safety.
How profitable is MED?
In FY2025, MEDIFAST INC had a net margin of -4.8% and a return on equity of -9.4%.
Is MED overvalued or undervalued?
MEDIFAST INC trades at about 61.0× trailing earnings — above its 10-year norm (10-year range 6.0×–82.6×, median 27.0×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for MED?
The average Wall-Street price target for MEDIFAST INC is $12.00, about 3.5% above the recent price, from 1 analysts.
Is MED a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on MEDIFAST INC: a Piotroski F-score of 3/9, an Altman Z″ in the safe zone, a dividend yield of 0.17%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.